5:57 PM
 | 
Oct 10, 2012
 |  BC Extra  |  Clinical News

Washington University to start trial in AD prevention

The Washington University School of Medicine in St. Louis announced plans for a placebo-controlled trial to evaluate Alzheimer's disease products from Roche (SIX:ROG; OTCQX:RHHBY) and Eli Lilly and Co. (NYSE:LLY) in 160 patients who have inherited mutations known to cause early...

Read the full 194 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >